Luqman A. Khan

Luqman A. Khan


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2021 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
RVRashi Verma
Rashi Verma
DPDibyabhaba Pradhan
Dibyabhaba Pradhan
ANArnab Nayek
Arnab Nayek
HSHarpreet Singh
Harpreet Singh
AJArun Kumar Jain
Arun Kumar Jain
LKLuqman A. Khan
Luqman A. Khan

1 January 2014 in Journal of Smooth Muscle Research
Verified
Journal Article
Open access
SKSwati Kundu
Swati Kundu
HSHiba Shabir
Hiba Shabir
SBSeemi Farhat Basir
Seemi Farhat Basir
LKLuqman A. Khan
Luqman A. Khan
Acute and chronic exposure to arsenic and mercury is known to produce vasoconstriction. There is, however, no clarity concerning the pathways leading to this increased contraction. In this study we elicit and compare maximum contractility of rat aortas under resting conditions in the presence of arsenic and mercury, and delineate pathways mediating this effect. Phenylephrine (PE) induced hypercontraction of 37% and 32% were obtained when isolated aortic segments were exposed to 25 ?M As(III) and 6 nM Hg(II), respectively. Isometric contraction measurements in presence of apocynin, verapamil and sodium nitroprusside indicates that the major causes of increased contraction are reactive oxygen species (ROS) and depletion of nitric oxide (NO). Calcium influx plays a minor role in arsenic and mercury caused hypercontraction. In unexposed aorta, eugenol causes relaxation by inhibiting ROS and elevating NO, linalool by blocking voltage dependent calcium channel (VDCC) and elevating NO, and carvone by blocking calcium influx through VDDC. Since the arsenic and mercury hypercontraction is mediated by increased ROS and depleted NO, we hypothesize that molecules which neutralize ROS or elevate NO will be better ameliorators. In line with this argument, we found eugenol to be the best ameliorator of arsenic and mercury hypercontraction followed by linalool and carvone.

8 October 2021 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
RVRashi Verma
Rashi Verma
DPDibyabhaba Pradhan
Dibyabhaba Pradhan
Ziaul HasanZiaul Hasan
Ziaul Hasan
HSHarpreet Singh
Harpreet Singh
AJArun Kumar Jain
Arun Kumar Jain
LKLuqman A. Khan
Luqman A. Khan
The emergence of antifungal drug resistance in Candida species has led to increased morbidity and mortality in immunocompromised patients. Understanding species distribution and antifungal drug resistance patterns is an essential step for novel drug development. A systematic review was performed addressing this challenge in India with keywords inclusive of ‘Candida’, ‘Antifungal Drug Resistance’, ‘Candidemia’, ‘Candidiasis’ and ‘India’. A total of 106 studies (January 1978–March 2020) from 20 Indian states were included. Of over 11,429 isolates, Candida albicans was the major species accounting for 37.95% of total isolates followed by C. tropicalis (29.40%), C. glabrata (11.68%) and C. parapsilosis (8.36%). Rates of antifungal resistance were highest in non-albicans Candida (NAC) species - C. haemuloni (47.16%), C. krusei (28.99%), C. lipolytica (28.89%) and C. glabrata (20.69%). Approximately 10.34% isolates of C. albicans were observed to be drug resistant. Candida species were frequently resistant to certain azoles (ketoconazole-22.2%, miconazole–22.1% and fluconazole–21.8%). In conclusion, the present systematic review illustrates the overall distribution and antifungal resistance pattern of Candida species among the Indian population that could be helpful in the future for the formation of treatment recommendations for the region but also elsewhere. A total of 106 studies were reviewed to define the prevalence, distribution and antifungal resistance pattern of Candida species in India. The presented data could become the point of reference for all reported findings on Candida species in India.

21 December 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ZHZiaul Hasan
Ziaul Hasan
AIAsimul Islam
Asimul Islam
LKLuqman A. Khan
Luqman A. Khan

29 July 2014 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
HSHiba Shabir
Hiba Shabir
SKSwati Kundu
Swati Kundu
SBSeemi Farhat Basir
Seemi Farhat Basir
LKLuqman A. Khan
Luqman A. Khan

1 June 2020 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
RVRashi Verma
Rashi Verma
DPDibyabhaba Pradhan
Dibyabhaba Pradhan
MMMohsin Maseet
Mohsin Maseet
HSHarpreet Singh
Harpreet Singh
AJArun Kumar Jain
Arun Kumar Jain
LKLuqman A. Khan
Luqman A. Khan